BioLife Solutions has executed an amendment to its current commercial lease to double the area of its existing facilities.
The additional space will be used to the build a second GMP manufacturing clean room suite and space for team members. BioLife Solutions chief executive officer Mike Rice said they are pleased to see demand for HypoThermosol and CryoStor continuing to increase.
“This growth, along with a new contract manufacturing customer we acquired late in 2011, will enable BioLife to create up to 10 additional jobs in manufacturing, quality assurance, sales, and marketing,” Rice added. BioLife Solutions chief financial officer Daphne Taylor said they look forward to increasing the company’s manufacturing capacity and the size of the team to meet the growing demand for its products and services.
The company said shipments to BioLife’s new contract manufacturing customer are expected to begin in the second quarter of this year. BioLife Solutions develops, manufactures and markets patented hypothermic storage and cryopreservation solutions for cells and tissues.
